About Celsius Holdings, Inc. - Common Stock (CELH)
Celsius Holdings Inc is a health and wellness company that specializes in the development and marketing of fitness drinks and nutritional products. The company's primary focus is on creating functional beverages that are designed to boost metabolism, enhance energy levels, and promote overall well-being. Celsius offers a range of products, including energy drinks, powdered drink mixes, and protein bars, targeting fitness enthusiasts and consumers looking for healthier lifestyle options. With a strong emphasis on innovation and product quality, Celsius aims to differentiate itself in a competitive market while promoting an active and health-conscious lifestyle. Read More
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q2. Today, we are looking at beverages, alcohol, and tobacco stocks, starting with Boston Beer (NYSE:SAM).
Growth boosts valuation multiples, but it doesn’t always last forever.
Companies that cannot maintain it are often penalized with large declines in market value, a lesson ingrained in investors who lost money in tech stocks during 2022.
As the craze of earnings season draws to a close, here’s a look back at some of the most exciting (and some less so) results from Q3. Today, we are looking at beverages, alcohol, and tobacco stocks, starting with Philip Morris (NYSE:PM).
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how beverages, alcohol, and tobacco stocks fared in Q3, starting with Celsius (NASDAQ:CELH).
Consumer staples stocks are solid insurance policies in frothy markets ripe for corrections. On the other hand, they usually underperform during bull runs,
and this paradigm has rung true over the past six months as the sector’s -7.4% decline paled in comparison to the S&P 500’s 17.2% gain.
Celsius Holdings, Inc. (Nasdaq: CELH) (“Celsius Holdings” or “the company”) today announced that its Board of Directors has authorized a new share repurchase program under which the company may repurchase up to $300 million of its outstanding common stock.
Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks.
But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models.
The Benzinga Stock Whisper Index looks at five stocks seeing increased attention from readers during the week and the catalysts that could be driving the rise.
Shares of energy drink company Celsius (NASDAQ:CELH)
fell 23.8% in the morning session after the company reported mixed earnings. The company announced impressive year-over-year revenue growth of 173% to $725.1 million, slightly ahead of estimates. Adjusted earnings per share of $0.42 also comfortably beat the consensus forecast. However, investors appeared to focus on the company's deteriorating profitability. Celsius reported a negative operating margin of 11%, a sharp decline from the negative 1.2% margin in the same quarter last year. This drop suggested that operating expenses, such as marketing and administrative costs, grew even faster than its impressive sales, raising concerns about its cost controls and the efficiency of its rapid expansion. Despite the strong top-line performance, the significant pressure on profitability seemed to spook investors, leading to the sharp sell-off.
After a brief and cautious rebound on Wednesday, risk-off sentiment returned sharply on Thursday, with AI-linked stocks leading a broad selloff across Wall Street and renewed pressure hitting crypto markets.
Celsius Holdings Q3 2025 earnings show 173% revenue growth, beating estimates. Adjusted EPS surged 50%, despite a GAAP net loss from acquisition costs.
Energy drink company Celsius (NASDAQ:CELH) reported Q3 CY2025 results topping the market’s revenue expectations, with sales up 173% year on year to $725.1 million. Its non-GAAP profit of $0.42 per share was 49.7% above analysts’ consensus estimates.
